Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
diphtheria toxoid (1 trial)
imiquimod (aldara) (1 trial)
inactivated influenza vaccine (2 trials)
Meningococcal (Groups A, C, Y, W) Conjugate Vaccine (MenQuadfi) (1 trial)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (2 trials)
tetanus toxoid (1 trial)
ad5-ncov (3 trials)
20-valent pneumococcal conjugate vaccine (Prevnar 20) (2 trials)
25 valent pneumococcal conjugate vaccine (2 trials)
bnt162b2 (Comirnaty) (1 trial)
chadox1 (1 trial)
mf59 (1 trial)
mrna-1273 (Spikevax) (1 trial)
chadox1-vzv (1 trial)
covac-2 (1 trial)
fb-631 (1 trial)
sodium chloride (1 trial)
varicella zoster virus glycoprotein e antigen (Shingrix) (1 trial)
vbi-2902a (1 trial)
vbi-2905a (1 trial)
oseltamivir (tamiflu) (1 trial)
Influenza, Human (Phase 4)
Meningococcal Infections (Phase 4)
Trials (15 total)
Trial APIs (21 total)